C12R 2001/445
Staphylococcus aureus
C12R2001/445 (Staphylococcus aureus) appears on 43 US grants and 71 published applications in this corpus.
Search patents in C12R- Granted patents
- 43
- Published applications
- 71
- Assignees
- 58
- Inventors
- 165
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 2 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 1 |
| 2009 | 1 | 1 |
| 2010 | 1 | 3 |
| 2011 | 2 | 1 |
| 2012 | 1 | 2 |
| 2013 | 2 | 1 |
| 2014 | 1 | 1 |
| 2015 | 2 | 3 |
| 2016 | 2 | 7 |
| 2017 | 6 | 2 |
| 2018 | 2 | 0 |
| 2019 | 1 | 2 |
| 2020 | 1 | 3 |
| 2021 | 1 | 3 |
| 2022 | 3 | 11 |
| 2023 | 3 | 6 |
| 2024 | 2 | 7 |
| 2025 | 3 | 8 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Immunoglobulin-binding protein and affinity support using same6 Jan 2026US 12,516,134 B2Jsr Corporation
- Lipid-encapsulated dual-cleaving endonuclease for DNA and gene editing4 Nov 2025US 12,460,192 B2Specific Biologics Inc.
- Lipid-encapsulated dual-cleaving endonuclease for DNA and gene editing27 May 2025US 12,312,615 B2Specific Biologics Inc.
- Lipid-encapsulated dual-cleaving endonuclease for DNA and gene editing13 May 2025US 12,297,467 B2Specific Biologics Inc.
- Binding moieties for biofilm remediation26 Nov 2024US 12,152,068 B2Trellis Bioscience, LLC
- Compositions and methods relating to epigenetic modulation30 Jul 2026US 2026/0218148 A1Duke University
- Affibody binding specifically to cd137 and use thereof23 Jul 2026US 2026/0209371 A1Abclon Inc.
- Lipid-encapsulated dual-cleaving endonuclease for dna and gene editing9 Apr 2026US 2026/0098248 A1Specific Biologics Inc.
- Treatment of organic waste29 Jan 2026US 2026/0028293 A1Biomax Holdings PTE LTD
- Lipid-encapsulated dual-cleaving endonuclease for dna and gene editing25 Sep 2025US 2025/0297238 A1Specific Biologics Inc.
Most cited
By later US patents
- Compositions and methods for treatment of microbial infections20US 6,929,798 B2Immunology Laboratories, Inc. · 2005
- Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof16US 6,251,647 B1The Rockefeller University · 2001
- Compositions and methods for treatment of microbial infections16US 7,329,409 B2Immunology Laboratories, Inc. · 2008
- Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof15US 6,013,507 AThe Rockefeller University · 2000
- Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof15US 6,063,613 AThe Rockefeller University · 2000